Skip to content

Clinical efficacy and safety study of HY-2019 on female hair loss

Clinical efficacy and safety study of HY-2019 on female hair loss

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500100505
Enrollment
Unknown
Registered
2025-04-10
Start date
2025-04-14
Completion date
Unknown
Last updated
2025-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hair Loss

Interventions

Test group:Use HY2019 according to requirements

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1. 18-50 years old, healthy female; 2. Savin classification is I-3, I-4, II-1, II-2 grades; 3. Has not undergone any special hair styling treatments such as dyeing, perming, or styling in the past month; 4. Be able to understand the research process, voluntarily participate in the research, and sign a written informed consent form.

Exclusion criteria

Exclusion criteria: 1. Planned pregnancy or pregnant or lactating women; 2. Have used hair products with anti-hair loss effects or other products with such effects in the past 3 months; 3. Have taken or locally used any medication that affects hair growth within the past 6 months; 4. Previously received hair transplant treatment; 5. Scars or injuries on the testing site; 6. Participated in other clinical studies within the past 2 months; 7. Researchers believe that it is not suitable to participate in the experiment.

Design outcomes

Primary

MeasureTime frame
Amount of local hair(terminal hair);

Secondary

MeasureTime frame
Safety assessment;

Countries

China

Contacts

Public ContactWang Xi

West China Hospital, Sichuan University

xierwang@126.com+86 28 8542 2300

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026